Welcome to
RBP World!
Drugs target to TERT
| Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
|---|---|---|---|---|---|---|
| IMETELSTAT | Oligonucleotide | myelofibrosis | Telomerase reverse transcriptase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| IMETELSTAT | Oligonucleotide | myelofibrosis | Telomerase reverse transcriptase inhibitor | 2.0 | Completed | ClinicalTrials |
| IMETELSTAT SODIUM | Oligonucleotide | neoplasm | Telomerase reverse transcriptase inhibitor | 1.0 | Completed | ClinicalTrials |
| IMETELSTAT | Oligonucleotide | breast cancer | Telomerase reverse transcriptase inhibitor | 1.0 | Completed | ClinicalTrials |
| IMETELSTAT | Oligonucleotide | myelodysplastic syndrome | Telomerase reverse transcriptase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| IMETELSTAT SODIUM | Oligonucleotide | lung cancer | Telomerase reverse transcriptase inhibitor | 1.0 | Completed | ClinicalTrials |
| IMETELSTAT | Oligonucleotide | polycythemia vera | Telomerase reverse transcriptase inhibitor | 2.0 | Completed | ClinicalTrials |
| IMETELSTAT | Oligonucleotide | myelofibrosis | Telomerase reverse transcriptase inhibitor | 3.0 | Recruiting | ClinicalTrials |
| IMETELSTAT | Oligonucleotide | lymphoma | Telomerase reverse transcriptase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| IMETELSTAT SODIUM | Oligonucleotide | breast cancer | Telomerase reverse transcriptase inhibitor | 2.0 | Completed | ClinicalTrials |
| IMETELSTAT | Oligonucleotide | multiple myeloma | Telomerase reverse transcriptase inhibitor | 2.0 | Completed | ClinicalTrials |
| IMETELSTAT SODIUM | Oligonucleotide | multiple myeloma | Telomerase reverse transcriptase inhibitor | 1.0 | Completed | ClinicalTrials |
| IMETELSTAT | Oligonucleotide | essential thrombocythemia | Telomerase reverse transcriptase inhibitor | 2.0 | Completed | ClinicalTrials |
| IMETELSTAT | Oligonucleotide | neuroblastoma | Telomerase reverse transcriptase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| IMETELSTAT | Oligonucleotide | non-small cell lung carcinoma | Telomerase reverse transcriptase inhibitor | 2.0 | Completed | ClinicalTrials |